Prediction of Cardiac Death in Hemodialysis Patients by Myocardial Fatty Acid Imaging

Journal of the American College of Cardiology

Volumn 51, Issue 2, 2008, Pages 139-145

  Nishimura, Masato ^a   Tsukamoto, Kazumasa ^b   Hasebe, Naoyuki ^c   Tamaki, Nagara ^d   Kikuchi, Kenjiro ^c   Ono, Toshihiko ^a  

^a Toujinkai Hospital   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IODINE 123; THALLIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HUMAN; IMAGING; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SCINTISCANNING; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY DISEASE; DEATH; DEATH, SUDDEN, CARDIAC; FATTY ACIDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 37849019203     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.08.057     Document Type: Article

References (29)

1. Collins A.J., Kasiske B., Herzog C., et al. Cardiovascular special studies. Excerpts from United States Renal Data System 2004 annual data report. Am J Kidney Dis 45 Suppl 1 (2005) S167-S178
2. Nakai S., Masakane I., Akiba T., et al. An overview of dialysis treatment in Japan (as of Dec. 31, 2005). J Japan Soc Dial Ther 40 (2007) 1-30
3. Foley R.N., Parfrey P.S., and Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 Suppl 12 (1998) S16-S23
4. Stack A.G., and Bloembergen W.E. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12 (2001) 1516-1523
5. Cheung A.K., Sarnak M.J., Yan G., et al., HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int 65 (2004) 2380-2389
6. Kawai Y., Tsukamoto E., Nozaki Y., Morita K., Sakurai M., and Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
7. Dilsizian V., Bateman T.M., Bergmann S.R., et al. Metabolic imaging with beta-methyl-p-[(123)]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112 (2005) 2169-2174
8. Nishimura M., Hashimoto T., Kobayashi H., et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 66 (2004) 811-819
9. Nohara R., Okuda K., Ogino M., et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 37 (1996) 1403-1407
10. Tamaki N., Kawamoto M., Yonekura Y., et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 33 (1992) 659-667
11. Fenchel G., Storf R., Michel J., and Hoffmeister H.E. Relationship between the high-energy phosphate content and various left ventricular functional parameters of the normal and hypertrophied heart after global ischemia and reperfusion. Thorac Cardiovasc Surg 36 (1988) 75-79
12. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart-a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
13. Sharir T., Germano G., Kavanagh P.B., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100 (1999) 1035-1042
14. Amann K., Wiest G., Neusüβ R., et al. Changes in vascular architecture independent of blood pressure in experimental uremia. Vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens 8 (1995) 409-417
15. Barenbrock M., Spieker C., Laske V., et al. Studies of vessel wall properties in hemodialysis patients. Kidney Int 45 (1994) 1397-1400
16. Amann K., Breitbach M., Ritz E., and Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 9 (1998) 1018-1022
17. 201Tl uptake in chronically hypoperfused myocardium: histologic correlation study. J Nucl Med 41 (2000) 293-296
18. Tamaki N., Tadamura E., Kawamoto M., et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 36 (1995) 1974-1980
19. Nakajima K., Shimizu K., Taki J., et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 36 (1995) 1934-1940
20. 123I-BMIPP in patients with stable angina pectoris. Nucl Med Commun 16 (1995) 1002-1008
21. Mori H., Sakamoto T., Ueda Y., and Yano K. Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid. J Cardiol 34 (1999) 61-69
22. Végh Á., and Parratt J.R. The role of mitochondrial KATP channels in antiarrhythmic effects of ischaemic preconditioning in dogs. Br J Pharmacol 137 (2002) 1107-1115
23. Kalliovalkama J., Jolma P., Tolvanen J.-P., et al. Potassium channel-mediated vasorelaxation is impaired in experimental renal failure. Am J Physiol 277 (1999) H1622-H1629
24. Brown J.H., Vites N.P., Testa H.J., et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 8 (1993) 433-437
25. Dahan M., Viron B.M., Faraggi M., et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54 (1998) 255-262
26. Hase H., Joki N., Ishikawa H., et al. Prognostic value of stress myocardial perfusion imaging using adnosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 19 (2004) 1161-1167
27. 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 31 (2004) 1512-1521
28. Chikamori T., Fujita H., Nanasato M., Toba M., and Nishimura T. Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 12 (2005) 172-178
29. Matsuki T., Nagara T., Nakata T., et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging 31 (2004) 1585-1591